Internal Medicine Doctors in Holladay, UT Accepting Medicare

3 Internal Medicine doctors found. Showing 1 - 3

George Landon Beales, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2146 Pheasant Lane, Holladay, UT 84121 Phone: 801-278-4965

Stephen B Smith, MD Internal Medicine - Hospice and Palliative Medicine Medicare: Accepting Medicare Assignments Practice Location: 1624 E 4500 S, Holladay, UT 84117 Phone: 801-266-7200    Fax: 801-266-7004

Dr. Sheetal Shah, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4252 S Highland Dr Ste 200, Holladay, UT 84124 Phone: 801-965-3600

News Archive

Smart technology for healthy longevity

A national policy is required for the research, demonstration, commercialisation and wide-scale deployment of smart technology for ageing-in-place to ensure: a healthy, safe, secure and fulfilling future for the increasing aged population in Australia by enabling them to remain at home longer, by easing the strain on the national healthcare system and providing cost effective solutions to meet the needs of the growing number of elderly Australians.

Glycogen study findings shed light on possible route to treat Lafora disease

Indiana University scientists have solved a perplexing mystery regarding one of the body's main energy storage molecules, in the process shedding light on a possible route to treatment of a rare but deadly disease in teenagers.

Omni Home agrees to pay the United States $1.97 million to settle claims

Omni Home Care, a home health care agency in Evansville, Ind., and its parent corporation, Omni Home Health, have agreed to pay the United States $1.97 million to settle claims that it violated the False Claims Act between 2006 and 2008, by failing to obtain certain required physician approvals before submitting bills for home health services to Medicare, the Justice Department announced today.

Microfluidic device mimics tumor microenvironment, helps drug discovery

One of the challenges that cancer researchers face in designing new antitumor agents is that of predicting how drug molecules will behave in the complex microenvironment that surrounds a tumor. In particular, tumors create all sorts of chemical and physical barriers that limit how much drug is able to enter a tumor, let alone reach cells deep within a tumor.

Polaris' ADI-PEG 20 novel anticancer drug inhibits growth of metastatic melanoma cells: Study

Physicians attending the annual meeting of the American Society of Clinical Oncology (ASCO) presented evidence that pegylated arginine deiminase (ADI-PEG 20), a novel anticancer drug that targets ASS(-) tumors, and which is being developed and manufactured by Polaris Group, was effective in inhibiting the growth of metastatic melanoma cells.

Read more Medical News

› Verified 2 days ago